Reishi-MRL

Reishi-MRL

Cultivation Process of Reishi-MRL

reishi
reishi

Mycology Research Laboratories Ltd.´s Ganoderma lucidum powder contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilised (autoclaved) substrate under ISO 22000:2018 standards in the EU.

This cultivation process ensures the powder complies with the EU regulation 1881/2006 for contamination of pesticides and heavy metals.

The cultivation system is proprietary, allowing for standardised production of Ganoderma lucidum.

Mycelium biomass of mushrooms offers a mixture of many co-operating and co-related healthful bioavailable ingredients prepared by nature itself – it is thus a truly pure natural product.

Mushrooms spend more than 90% of their life cycle in the mycelium. Since mushrooms cannot produce their own energy through photosynthesis, the mycelium must be able to actively obtain or produce extracellular compounds and metabolites that promote the longevity and vitality of the living mushroom. These properties lie behind the high enzymatic activity of the mycelium, which stays preserved in the carefully processed MRL products.

Manufacturing Process of Reishi-MRL in tablets presentations

The Ganoderma lucidum lucidum tablets are processed under FSSC 22000 standards in the Netherlands. This ensures that each tablet of 500 mg contains standardised Ganoderma lucidum product. The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.

After passing quality control testing the tablets are released for use. The choice of additives used in manufacture renders these tablets suitable for Kosher or vegetarian use.

Manufacturing Process of Reishi-MRL in powder presentations

The Ganoderma lucidum biomass and all the powder presentations are produced and manufactured in accordance with both EU and UK organic standards.

EU PT Bio 05 Logo
EU PT Bio 05 Logo
UK Organic Logo
UK Organic Logo

Chemical and Biological Properties *

Each Tablet of Reishi-MRL contains

Ganoderma lucidum - biomass powder 500 mg

Other ingredients

Microcrystalline Cellulose
Silica
Vegetable Magnesium Sterate

Reishi-MRL - Enzyme Activity Per 750 mg Tablet

Protein content 22.2 mg
Reducing sugars 24.0 mg
Protein-bound polysaccharide 69.5 mg
Glucose 2-oxidase activity 8.2 mU
Peroxidase activity 11.2 mU
Laccase activity 451.5 mU
Glucoamylase / beta-glucansase activity 2.7 U
Protease activity 4.4 mU
Superoxide dismutase (SOD) activity 50.4 mU
Cytochrome P-450 0.66 nmoles
Cytochrome P-450 reductase 7.05 mU
Secondary metabolites (Thrombin inhibitors) 4.4%